▲ S&P 500 +---% | ▲ Stock Advisor +---% Join The Motley Fool

Accessibility Log In Help

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Daily Stock Gainers Daily Stock Losers Most Active Stocks

Maxx Chatsko

XMFBlacknGoldX

Maxx has been a contributor to Fool.com since 2013. He graduated from the State University of New York College of Environmental Science and Forestry (2012) with a Bachelor of Science in Bioprocess Engineering and from Carnegie Mellon University (2016) with a Master of Science in Materials Science & Engineering.

Recent Articles by Maxx Chatsko

stock down erased chalkboard

Jun 12, 2020 by Maxx Chatsko

Here's Why Selecta Biosciences Is Tumbling Today

A licensing deal for a late-stage asset failed to impress Wall Street. One analyst went as far as downgrading the biopharma stock.

blocks arrows rising

Jun 12, 2020 by Maxx Chatsko

2 Top Small-Cap Stocks to Buy Right Now

Volatile stock market or not, these two drug developers are well positioned for long-term success.

stock down angry fist

Jun 11, 2020 by Maxx Chatsko

Here's Why Alliance Resource Partners Fell as Much as 13.5% Today

The Fed thinks the economy will take more time to recover than Wall Street was expecting, which is bad news for this coal stock.

stock down finger

Jun 11, 2020 by Maxx Chatsko

Here's Why Invitae Fell as Much as 10.1% Today

The growth stock is an easy target in a volatile market.

chalkboard stock down pink

Jun 11, 2020 by Maxx Chatsko

Here's Why Renewable Energy Group Dropped Over 10% Today

The small-cap stock hit an all-time high earlier this month, but gloomy economic outlooks have investors rethinking the company's valuation.

arrow up shelves

Jun 10, 2020 by Maxx Chatsko

New Gold Rises as Much as 12.9% on Series of Financing Deals

The gold miner is making moves to improve its near-term financial flexibility.

business growth

Jun 9, 2020 by Maxx Chatsko

Here's Why Albemarle Gained 24.6% in May

The world's leading lithium producer benefitted from rising confidence about the pace of a possible economic recovery.

076 arrow dude getty

Jun 9, 2020 by Maxx Chatsko

Here's Why AnaptysBio Rose 22.1% in May

The beaten-up biopharma provided an update that revved up interest in its pipeline.

businessman rocket

Jun 9, 2020 by Maxx Chatsko

Here's Why CymaBay Therapeutics Rose 109% in May

The development-stage company might be able to resume the development of its lead drug candidate, which was halted in late 2019.

blocks arrows rising

Jun 9, 2020 by Maxx Chatsko

Here's Why Athersys Rose 26.5% in May

The stem cell stock recovered from a lousy April as the company fed investors updates for its COVID-19 programs.

arrow up shelves

Jun 9, 2020 by Maxx Chatsko

Here's Why TG Therapeutics Jumped 58.6% in May

The development-stage company appears to be on the path to commercial operations.

dude tossing stacks

Jun 9, 2020 by Maxx Chatsko

Here's Why Fate Therapeutics Rose 18.4% in May

The cell therapy developer announced the next step for an important pipeline asset.

302 growth stock

Jun 9, 2020 by Maxx Chatsko

2 Top Growth Stocks to Buy in June

The stock market is expensive, but these two energy stocks have long-term tailwinds supporting their growth strategies.

worker transmission grid

Jun 3, 2020 by Maxx Chatsko

The Next Big Obstacle in Renewable Energy Is a Big Opportunity for Investors

The United States could add a record 33,000 megawatts of renewables to the grid in 2020, but a record build out of transmission will be needed to keep growth humming along.

171 tug of war

Jun 3, 2020 by Maxx Chatsko

The Debate Is Over: This Cancer Stock Is Winning the GIST Race

Blueprint Medicines and Deciphera Pharmaceuticals were going toe-to-toe developing treatments for this rare cancer. Investors can now call the winner.

people re cut outs

Jun 2, 2020 by Maxx Chatsko

Party Like It's 1880: Renewable Energy Consumption Surpasses Coal

The last time the feat was accomplished, the United States relied primarily on wood for energy. There's no turning back now.

563 shocked phone

Jun 1, 2020 by Maxx Chatsko

Here's Why Amyris Is Soaring Today

A bullish article is pushing shares higher, but investors need to remain grounded.

funky arrows rising

Jun 1, 2020 by Maxx Chatsko

Here's Why Intellia Therapeutics Gained as Much as 18.0% Today

An existing partner is doubling down on the gene editing platform.

029 is stock a buy

Jun 1, 2020 by Maxx Chatsko

Is Catalent a Buy?

A combination of acquisitions and coronavirus vaccine manufacturing deals have pushed shares to an all-time high, but not all earnings are flowing to common stockholders.

563 shocked phone

May 30, 2020 by Maxx Chatsko

2 Stats Show the Dire State of U.S. Coal-Fired Power Plants

The first-quarter performance of America's dirtiest power source was the worst in decades, but there are opportunities in coal's demise.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services